Methotrexate: clinical pharmacology, current status and therapeutic guidelines
- 1 June 1977
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 4 (2) , 87-101
- https://doi.org/10.1016/s0305-7372(77)80007-8
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Failure of leucovorin rescue to prevent reactivation of a solar burn after high dose methotrexateCancer, 1976
- Methotrexate in Liver and Bile after Intravenous Dosage in ManBritish Journal of Cancer, 1973
- Neurotoxicity and Elevated Cerebrospinal-Fluid Methotrexate Concentration in Meningeal LeukemiaNew England Journal of Medicine, 1973
- Methyltetrahydrofolic Acid Mediates N - and O -Methylation of Biogenic AminesScience, 1973
- Threshold Methotrexate Concentration for In Vivo Inhibition of DNA Synthesis in Normal and Tumorous Target TissuesJournal of Clinical Investigation, 1973
- Enzymatic Cleavage of Methotrexate provides a Method for Prevention of Drug ToxicityNature, 1972
- Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancerCancer, 1972
- Methotrexate Therapy of Wegener's GranulomatosisAnnals of Internal Medicine, 1971
- Acute lymphocytic leukemia in children: maintenance therapy with methotrexat administered intermittently. Acute Leukemia Group BPublished by American Medical Association (AMA) ,1969
- Increased Level of Dihydrofolic Reductase in Leucocytes of Patients Treated with AmethopterinNature, 1962